Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement onForm S-3 of our reportdated February 28, 2018relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Valeant Pharmaceuticals International, Inc.’s Annual Report on Form10-K for the year ended December 31, 2017. We also consent to the reference to us under the heading “Experts”in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
February 28, 2018
